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Abstract: The ingestion of gluten-containing foods can cause wheat-related disorders in up to 15% of
wheat consuming populations. Besides the role of gluten, α-amylase/trypsin inhibitors (ATI) have
recently been identified as inducers of an innate immune response via toll-like receptor 4 in celiac
disease and non-celiac wheat sensitivity. ATI are involved in plant self-defense against insects and
possibly in grain development. Notably, they are largely resistant to gastrointestinal proteases and
heat, and their inflammatory activity affects not only the intestine, but also peripheral organs. The aim
of this study was to understand the changes of ATI throughout the sourdough and yeast-fermented
bread-making processes. ATI tetramers were isolated, fluorescein-labelled, and added to a mini-dough
bread-making system. When the pH decreased below 4.0 in sourdough fermentation, the ATI
tetramers were degraded due to the activation of aspartic proteases, whilst in yeast fermentation,
ATI tetramers remained intact. The amylase inhibitory activity after sourdough fermentation decreased
significantly, while the concentration of free thiol groups increased. The glutathione reductase activity
of Fructilactobacillus sanfranciscensis did not contribute to the reduction of ATI tetramers. Compared to
the unfermented wheat, sourdough fermentation was able to decrease the release of pro-inflammatory
cytokines monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor alpha (TNF-α) in
quantitative ATI extracts added to the human monocytic cell line THP-1. The current data suggest
that sourdough fermentation can degrade ATI structure and bioactivity, and point to strategies to
improve product development for wheat sensitivity patients.
Keywords: wheat sensitivity; bioactivity; innate immunity; fermentation; lactic acid bacteria
1. Introduction
Wheat is a major staple food for human consumption, and wheat ingredients have been widely
used for processed foods. However, an increasing number of people suffer from wheat-related
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disorders. Of these wheat related disorders, non-celiac wheat sensitivity (NCWS) is a heterogeneous
and poorly defined condition that is diagnosed by exclusion of other wheat-induced immunological
disorders, including allergies, wheat-dependent exercise-induced anaphylaxis, and autoimmune
diseases such as celiac disease, gluten ataxia, and dermatitis herpetiformis [1–5]. NCWS is manifested
by intestinal and multiple extra-intestinal complaints, while standard endoscopic workup and routine
laboratory parameters are usually normal [3]. Intestinal and extra-intestinal symptoms of NCWS
can overlap with celiac disease (CD) and irritable bowel syndrome (IBS) [6,7]. CD affects about
1% of most human populations, has a strong genetic component, and is caused by an adaptive,
i.e., T-cell-mediated, immune response to defined gluten peptides after their modification by the
autoantigen tissue transglutaminase [8–10].
Intestinal symptoms of NCWS are not triggered by gluten proteins but relate to wheat fructans,
which protect the plant in cold and drought conditions, as well as wheat proteins including
amylase trypsin inhibitors that protect the wheat grain against herbivores and fungal attack [11,12].
A pro-inflammatory effect is best documented for α-amylase/trypsin inhibitors (ATIs) that activate the
toll-like receptor 4 (TLR4) complex on myeloid cells, monocytes, macrophages, and dendritic cells,
to induce a mild intestinal inflammation, disturb tight junctional integrity, and promote extra-intestinal
diseases like allergies, the metabolic syndrome, and fatty liver disease [13–18]. ATI are also prominent
allergens in immediate-type, immunoglobulin E (IgE)-Antibody-positive allergies, such as bakers’
asthma [1]. Moreover, atypical IgE and skin test-negative wheat allergies are a prominent cause of
IBS [4,5]. Therefore, ATI are considered important contributors to CD and NCWS but also other
intestinal and extra-intestinal immune disorders [2,7,19,20].
ATI are present in many plants and play a protective role by inhibition of α-amylases from insects
and mites [21]. ATI are associated with storage proteins in endosperm and are involved in grain
maturation [22]. In bread wheat, ATI represent up to 4% of total wheat proteins, and consist of at least
14 types of subunit proteins [23]. The nomenclature of ATI subunits is inconsistent. They include
wheat ATI monomer with molecular weight (MW) 12 kDa, often referred to as 0.28 inhibitor based on
its electrophoretic mobility, ATI homodimer with MW 24 kDa, referred to as 0.19 and 0.53 inhibitors,
and ATI heterotetramers with MW 60 kDa, also referred to as CM proteins. CM proteins, termed for their
solubility in chloroform:methanol mixtures, include subunits CM1, CM2, CM3, CM16, and CM17 [23].
Each ATI subunit ranges from about 11 to 16 kDa in MW and contains 10 cysteine residues (except
ATI 0.53 with 9 cysteine residues) that form five intramolecular disulfide bonds while dimers and
tetramers associate in a non-covalent manner [23]. The multimeric forms of ATI determine their
biological activity and the ATI tetramer is five times more active than the monomer [14]. In addition,
the compact, highly disulfide-linked secondary structure of ATI is needed for their biological activity,
i.e., the activation of TLR4 [13]. Reduction of these disulfide bonds or hydrolysis of ATI by proteinase K
significantly decreased their bioactivity [13]. Primary structures are also involved, since 2 peptides were
identified that inhibited the interaction of CM3 with TLR4 [24]. CM3 and 0.19 are the most prevalent ATI
species, and were shown to have comparable bioactivity when expressed recombinantly in eukaryotic
cells [13]. ATI of gluten-containing grains (wheat, barley, and rye) have potent inflammatory activity,
while structurally less related ATI of oats, maize, rice, and legumes have no or low activity [14].
Food processing alters the conformation of allergen proteins and may abolish, and in rarer cases,
increase their allergenicity [25]. In one study, IgE-antibodies of wheat-allergic patients reacted with
in vitro digested bread crumb and crust, but not with unheated bread dough [26]. The TLR4-stimulating
bioactivity of ATI is reduced by 20–50% after bread- and biscuit-making, compared to unprocessed
wheat flour [14]. Malting and germination activates cereal endogenous proteolytic enzymes and induces
the degradation of gluten proteins and celiac-toxic gluten epitopes [27–29]. Sourdough fermentation
also alters the composition and activity of wheat proteins, since it reduces the pH to the optimum pH
of endogenous cereal proteases and thus stimulates proteolysis [28,30]. In addition, heterofermentative
lactobacilli in sourdough accumulate glutathione, resulting in the reduction of intramolecular and
intermolecular disulfide bridges in wheat gluten and other proteins [28,31]. Sourdough fermentation
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is widely used in artisanal and industrial bread production [32], however, the changes of the
immunologically highly relevant ATI during production of sourdough bread remains undefined.
The aim of this study was to investigate the wheat ATI tetramers in wheat sourdough- and
yeast-fermentation bread-making. This study provides fundamental knowledge on the molecular
changes of ATI tetramer due to fermentation, proteolytic, and heat treatment during these two
bread-making processes. The fate of ATI was assessed by a three-pronged approach including (i) the
analysis of dough proteins by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE)
and assessment of the inhibition of amylases by these proteins, (ii) the assessment of fluorescein-labelled
ATI tetramer in sourdough fermentation and a model bread-making protocol, and (iii) the assessment
of the inflammatory activity of sourdough extracts. To assess the role of cereal aspartic proteases and
the microbial accumulation of low molecular weight thiols, sourdough fermentations were carried out
in presence of protease inhibitors, and with isogenic strains of Fructilactobacillus sanfranciscensis that
differ with respect to glutathione reductase activity.
2. Materials and Methods
2.1. Sourdough and Yeast Dough Making
Pastry wheat flour (hexaploid endosperm white flour) with no ascorbic acid (protein content
12.5%) and rye sourdough starter were supplied from Fazer Mills, Lahti, Finland. Fermaid SSR inactive
yeast containing 2.5–3% glutathione (GSH) was obtained from Lallemand, Finland. Fresh yeast was
purchased from Suomen Hiiva Oy, Lahti, Finland. Dough yield for both sourdough and yeast dough
was 200. Doughs 1, 2, and 3 contained 250 g flour, 250 g water, and 5 g fresh yeast. Doughs 4 and 5
contained 250 g flour, 250 g water, 5 g GSH-containing inactive yeast, and 5 g fresh yeast. Dough 6,
as a chemical-acidified dough control, contained 250 g flour and 250 mL 200 mM Na Acetate at pH 3.5.
Dough 7, wheat sourdough, contained 250 g flour, 250 g water, and 15 g rye sourdough starter. Dough 8
consisted of 250 g flour, 250 mL 200 mM Na Acetate, pH 3.5, and 5 g inactive yeast. The mixing time
was 5 min with a HOBART dough mixer. The fermentation time and temperature for each dough was:
Dough 1, 30 ◦C, 1 h; Dough 2, 30 ◦C, 17 h; Dough 3, 4 ◦C, 17 h; Dough 4, 30 ◦C, 1 h; Dough 5, 30 ◦C,
17 h; Dough 6, 30 ◦C, 17 h; Dough 7, 30 ◦C, 17 h; Dough 8, 30 ◦C, 17 h. The pH of each dough at the end
of the fermentation was measured with a Lab pH meter PHM 92 (Radiometer Copenhagen).
2.2. SDS-PAGE
The yeast doughs and sourdoughs were lyophilized and grounded in a mortar. An aliquot
of 2 g dried dough flour was extracted with 150 mM NaCl at ambient temperature to separate the
albumin/globulin fraction of the dough flour. The protein solution was also heated at 60 ◦C for 30 min
to inactivate beta-amylases and then the supernatant was dialyzed against water to remove the salt
by a membrane cut-off of 3.5 kDa. Followed by lyophilization, the albumin/globulin fraction of
dough flour before and after heat treatment were analyzed by SDS-PAGE. Wheat flour as control was
treated as described before. The dried samples were mixed with 4× lithium dodecyl sulfate (LDS)
sample buffer and 10× sample reducing agent and boiled for 3 min and separated on NuPage Bis-Tris
10% gel with MES (2-(N-morpholino)ethanesulfonic acid) SDS running buffer (Invitrogen, Thermo
Fisher Scientific, Waltham, MA, USA). Novex Sharp pre-stained protein standard (LC5800) or SeeBlue
Plus2 Pre-stained standard (LC5925, Thermo Fisher Scientific) served as molecular markers (myosin
198 kDa, phosphorylase 98 kDa, bovine serum albumin 62 kDa, glutamic dehydrogenase 49 kDa,
alcohol dehydrogenase 38 kDa, carbonic anhydrase 28 kDa, myoglobulin 17 kDa, lysozyme 14 kDa,
and aprotinin 6 kDa). Running condition was 200 V for 35 min. The gel was stained by Commaasie
Brilliant Blue R-250.
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2.3. Amylase Inhibitory Activity
A 100 mg aliquot of the albumin/globulin fraction of dough flour was dissolved in 1 mL 150 mM
NaCl, and the protein concentration was measured by the Lowry method (Detergent compatible
DC Protein assay, BioRad), and adjusted to the same concentration for each dough. The amylase
inhibitory activity of the dough albumin/globulin fraction was measured using soluble potato starch
(Sigma S2630) and α-amylase from porcine pancreas (PPA) (Sigma A3176) or crude α-amylase extract
from the yellow mealworm Tenebrio molitor (TMA). For PPA, the reaction was conducted in the
presence of 50 mM sodium phosphate, 50 mM NaCl, 0.5 mM CaCl2, 0.1% BSA, and pH 6.9, while for
TMA it was performed in 20 mM Na-acetate, 100 mM NaCl, 1 mM CaCl2, 0.1% BSA, and pH 5.4 at
ambient temperature [33]. A control sample was only incubated with the enzyme. The release of the
maltose was measured spectrophotometrically at 540 nm, with a series of maltose solution standards,
after reaction with 3,5-dinitrosalicylic acid. Inhibition percentage of each dough was counted as
=(Controlmaltose − Doughmaltose)/Controlmaltose × 100%. Each assay was performed in triplicates.
2.4. Determination of Free Thiols
The albumin/globulin fraction of 9 mg freeze-dried dough flour was completely dissolved in 1 mL
of 5% sodium dodecyl sulfate (SDS), 0.1 M Tris-HCl, pH 8.0, buffer at 60 ◦C for one hour. 100 µL of the
solution was diluted with 900 µL 0.1 M Tris-HCl, pH 8.0, and mixed with 50 µL 10 mM DTNB (Ellman’s
reagent, 5,5-dithio-bis-(2-nitrobenzoic acid)). Absorbance at 412 nm before and after adding DTNB was
measured. Protein concentration was determined at 280 nm. The thiol content was calculated using
molar extinction coefficient ∆ε412 = 14,150 M−1 cm−1, and expressed as µM/mg protein. Each assay
was performed in triplicates.
2.5. Isolation and Characterization of ATI
Wheat flour was defatted with methanol:diethyl ether (1:1, v/v) and extracted with 150 mM NaCl
(m/v) at a 1:5 ratio overnight at 4 ◦C. After centrifugation at 15,000× g, the supernatant was collected
and proteins were precipitated by 20% ammonium sulfate at ambient temperature. The precipitated
proteins were dissolved in 100 mM ammonium acetate, pH 6.9, and dialyzed against the same buffer
overnight. The protein solution was cleared by centrifugation and heat-treated at 70 ◦C for one hour to
denature all β-amylases. After centrifugation, the crude extract was loaded on a size-exclusion column
with Sephadex G-100 (100 cm × 26 mm) connected to an Äktä prime plus system (GE Healthcare,
Uppsala, Sweden), and eluted with the same acetate buffer (flow rate 0.5 mL/min). Fractions with
molecular size around 60 kDa were collected according to the marker BSA (66 kDa). The fractions were
combined, dialyzed, and lyophilized for the study of ATI tetramers. For identification, the amylase
inhibitory activity of the collected fractions against α-amylase from porcine pancreas (PPA) and
α-amylase from Tenebrio molitor (TMA) was confirmed. The SDS-PAGE gel bands at Mr 15 kDa
were excised for mass spectrometry MS identification. In short, the proteins were reduced and
alkylated and in-gel digested with sequencing grade trypsin (Promega, Madison, WI, USA) overnight
at 37 ◦C. The tryptic peptides were identified by matrix-assisted laser desorption ionization tandem
time-of-flight (MALDI-TOF/TOF) (UltrafleXtreme 2000 Hz, Bruker Daltonics, Bremen, Germany) using
a matrix solution of α-cyano-4-hydroxy cinnamic acid (Sigma, USA). The identified peptides were
searched against the SwissProt sequences from Triticum aestivum using Matrix Science’s Mascot Daemon
(Matrix Science Ltd. London, UK). The searching parameters were 0.1 Da precursor tolerance, 1 Da
MS/MS fragment tolerance, fixed modification of carbamidomethylation of cysteine, and variable
modification of oxidation of methionine, and one trypsin miscleavage was allowed. Proteins were
identified by their unique peptides [34].
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2.6. Sourdough and Yeast Bread-Making with Fluorescein-Labelled ATI
Isolated ATI tetramer at 20 mg/mL in 100 mM pH = 9.0 sodium carbonate-bicarbonate buffer was
reacted with 10 mg/mL fluorescein isothiocyanate (FITC) in dimethyl sulfoxide (DMSO) for two hours
in the dark. The excess FITC was removed by gel filtration on a PD-10 column and FITC-labelled
ATI tetramer was eluted with 50 mM sodium phosphate, pH 6.9. Purified FITC-labelled ATI solution
was added to mini-dough systems to follow its changes during bread-making. Type I sourdough
bread includes two stages of fermentation. The first stage is long time sourdough fermentation mainly
with lactobacilli, and the second stage is bread dough fermentation with the addition of wheat flour
and baker’s yeast. Yeast bread is only one stage fermentation with direct addition of baker’s yeast.
The mini-sourdough was prepared by mixing 1.5 g pastry white wheat flour (hexaploid modern) with
1.5 g water plus the inoculums or rye sourdough starter (5% m/m), and fermented for 24 h at 30 ◦C.
For the bread dough, an additional 3.5 g of wheat flour was added together with 1.5 g water, including
1% (m/m) dried yeast (Active dry yeast, Fleischmann’s, Mississauga, ON, Canada), 2% (m/m) salt,
and 2% (m/m) sugar. After yeast fermentation for 2.5 h at 30 ◦C, the bread dough was placed in a
boiling water bath for 8 min until the dough temperature reached 95 ◦C. The labelled ATI was dosed
as 1% of wheat flour protein at both the sourdough and bread dough stage, respectively. Samples were
taken for analysis of labelled ATI at the sourdough stage (A): A1: after sourdough mixing as control,
A2: after lactobacilli fermentation, A3: after yeast fermentation, and A4: after baking. At the bread
dough stage (B): B1: after bread dough mixing, B2: after yeast fermentation, and B3: after baking.
Yeast bread was prepared with 5 g wheat flour, 3 g water, 1% (m/m) dried yeast, 6 mg labelled ATI (1%
of wheat flour protein), and fermented at 30 ◦C for 2.5 h (wheat fermentation stages, Y): Y1: after dough
mixing, Y2: after yeast fermentation, and Y3: after baking. After sourdough fermentation, pH and cell
counts were analyzed immediately.
The inoculum Fructilactobacillus sanfranciscensis DSM20451T (previously:
Lactobacillus sanfranciscensis) [35] were cultivated in modified MRS (De Man, Rogosa and
Sharpe) agar with 10 g/L maltose and 5 g/L fructose anaerobically at 30 ◦C, and mutant F. sanfranciscensis
DSM20451T ∆gshR, without glutathione reductase activity [31], were cultivated with an additional
10 mg/L erythromycin. The rye sourdough starter consisted of lactic acid bacteria in 9 log
colony-forming units (CFU) g−1 including F. sanfranciscensis, Lactobacillus crispatus, Weissella cibaria,
and yeast Kazachstania humilis in 7 log CFU g−1. Chemically acidified doughs were prepared by
mixing 1.5 g wheat flour and 1.5 g solution mixture of lactic acid and acetic acid at pH 4.0 and pH 5.0,
respectively. Bacterial cell counts were monitored by plating appropriate dilution of sourdough
samples with mMRS agar and incubated anaerobically at 30 ◦C for 2–3 days using the Whitley
automatic spiral plater (Whitley Scientific, Bingley, UK) [31].
2.7. Confirmation of Single Strain Fermentation by qPCR (Quantitative Polymerase Chain Reaction)
The identity of the strains F. sanfranciscensis DSM20451T, and F. sanfranciscensis DSM20451T ∆gshR
was confirmed by high-resolution melting quantitative PCR (HRM-qPCR) following the conditions
described by Lin and Gänzle [36]. In short, 30 mg of freeze-dried sourdough sample were mixed with
2.5 mL of sterile 0.8% (w/v) NaCl solution. The mixture was centrifuged at 5000× g for 5 min and
supernatant was collected. The supernatant was centrifuged at 5000× g for 15 min to harvest the cells.
DNA was extracted using a DNeasy Blood and Tissue Kit (Qiagen, Germantown, MD, USA). For the
PCR, a Rotor-Gene Q (Qiagen, Germantown, MD, USA) and Type-it HRM PCR Kit (Qiagen, Qiagen,
Germantown, MD, USA) were used. The primers for the Experiment were Universal Primers targeting
16S (forward, 5′-TCC TAC GGG AGG CAG CAG T-3′; reverse, 5′-GGA CTA CCA GGG TAT CTA ATC
CTG TT-3′). The conditions for the HRM-qPCR were denaturation for 5 min at 95 ◦C, then 45 cycles
of denaturation at 95 ◦C for 10 s, annealing at 60 ◦C for 30 s, and extension at 72 ◦C for 10 s. For the
final stage, the temperature was raised from 65 ◦C to 90 ◦C at 0.1 ◦C increments for 2 s at each step.
The software used to process the data was PeakFit Software (Systat Software Inc., San Jose, CA, USA).
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2.8. Analytical Size-Exclusion Chromatography
The samples collected from the mini-dough systems were lyophilized and ground in a mortar.
The proteins were extracted from a 100 mg dried flour sample with 1 mL of 100 mM ammonium
acetate, pH 6.9, filtered through a 0.45 µm pore membrane, and separated on a Superdex Peptide
10/300 GL column (GE Healthcare, Life Sciences) coupled to an Agilent 1200 high-performance
liquid chromatography (HPLC) system with a diode array detector and a fluorescence detector
(excitation = 488 nm, emission = 530 nm) at a flow rate of 0.5 mL/min in 100 mM ammonium acetate,
pH 6.9, at ambient temperature. BSA (66 kDa), lysozome (14 kDa), and GSH (307 Da) served as
standards. The ATI tetramer and monomer were identified by elution volume and fluorescence
detection. The peak height ratio (tetramer:tetramer + monomer) was calculated to demonstrate ATI
tetramer dissociation/degradation.
2.9. Sourdough Fermentation in the Presence of Protease Inhibitors
The sourdough contained 250 g flour, 250 g water, and 15 g rye sourdough starter in the presence
of 20 µM aspartic protease inhibitor Pepstatin-A or 10 µM cysteine protease inhibitor E-64, (1S,2S)-2-
(((S)-1-((4-Guanidinobutyl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)cyclopropanecarboxylic acid,
respectively. After lyophilization, the albumin/globulin extract of the dough flour was heat-treated
and analyzed as in Section 2.2 by SDS-PAGE. To investigate the proteases effect on ATI tetramer,
the same concentration of Pepstatin-A or E-64 was added to the mini-dough systems respectively,
where fluorescein-labelled ATI tetramer was included. The fermentation was carried out for 17 h at
30 ◦C and the dough pH was measured at the end of the fermentation. The ATI tetramer was then
analyzed by size-exclusion chromatography coupled with a fluorescence detector, as described in
Section 2.8.
2.10. Bioactivity of Sourdough
Whole grain wheat flour was fermented with F. sanfranciscensis DSM20451T, F. sanfranciscensis
DSM20451T ∆gshR, Limosilactobacillus reuteri LTH5448 (previously Lactobacillus reuteri),
or Latilactobacillus sakei LS8 (previously Lactobacillus sakei) [35], as described above, and the
reaction was terminated by lyophillization. ATI (TLR4-stimulating) bioactivity was determined as
described before [14,15]. Briefly, 1 g of fermented and lyophilized sourdough samples was sieved
and defatted with 10 times (w/v) methanol/diethyl ether 1:1 (v/v) for 2 h at ambient temperature with
constant stirring, followed by centrifugation at 2500× g for 20 min. After drying, the pellet was
extracted with 5 volumes (w/v) 50 mM ammonium bicarbonate, pH 7.8, overnight at 4 ◦C, and the
supernatant was saved. A second consecutive extraction under the same conditions was performed,
which contributed another 20% of total extractable ATI, equivalent to 90–95% of total extractable
ATI activity [14]. Protein content was measured using the bicinchoninic acid assay (Thermo Fisher
Scientific, Bonn, Germany). The two extractions were combined, diluted in phosphate-buffered saline
(PBS) or cell culture medium, and extracts with 10–250 µg protein/mL were added to mycoplasma-free
cultures of ATI-reactive (TLR4-bearing) human THP-1 monocytes cells (TIB-202, ATCC, Wesel,
Germany), seeded at densities of 2 × 105 to 1 × 106/mL in 0.2 to 1 mL medium in 96- or 24-well
culture plates. An extract of a standard commercial wheat flour, bacterial lipopolysaccharide (LPS),
or a blank control served as positive and negative controls, respectively. After a 0.5–16 h incubation,
chemokines and cytokines released into the medium were quantified with validated enzyme-linked
immunosorbent assays (ELISAs) for CCL2/MCP-1 and TNF-α (BD, Heidelberg; eBioscience, Frankfurt,
Germany; R&D systems, Minneapolis, MN, USA).
2.11. Statistical Analysis
The significance test of amylase inhibition activity and free thiol groups results were conducted
by SPSS 10.0, using one-way analysis of variance (ANOVA) and Tukey’s honest significance test (HSD)
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test (p < 0.05). Bioactivity statistical analysis was performed by one-way ANOVA multivariate analysis
followed by Dunnett’s post-hoc test using Graph-Pad Prism v.6.0. p < 0.05 was considered significant.
3. Results
3.1. Changes of the Albumin/Globulin Fraction after Sourdough and Yeast Fermentation
The electrophoretic patterns characterize the composition of the albumin/globulin fractions before,
during, and after sourdough and yeast fermentation (Figure 1). In general, sourdough 6, 7, and 8, with a
final pH 3.5–3.7, showed a more intensive hydrolysis, and β-amylases with a molecular size around
60 kDa were degraded after sourdough fermentation, while they remained present after conventional
flour and yeast fermentation (Figure 1A). After heat denaturation, yeast dough 2 and 5, extracted at a
lower pH of 4.6, lead to precipitation of most β-amylases compared to yeast dough 1, 3, and 4, with the
higher pH of 5.5, 5.4, and 5.6. Dough 1, 3, and 4 showed the same gel band patterns as native flour.
In sourdough 6, 7, and 8, increased protein products of low molecular weight around 14 kDa were
present (Figure 1B). Proteolysis in chemically acidified doughs and in sourdoughs has been attributed
to gluten-associated aspartic proteases [28]; therefore, sourdough fermentation was also conducted in
the presence of Pepstatin-A, an inhibitor of aspartic proteases, and in the presence of E64, an inhibitor
of cysteine peptidases (Figure 2A). Proteolysis in sourdoughs was inhibited by Pepstatin-A but not by
E-64, confirming the pH-dependent role of aspartic proteases on protein modifications (Figure 2A).
Foods 2020, 9, x FOR PEER REVIEW 7 of 18 
 
3. Results 
3.1. Changes of the Albumin/Globulin Fraction after Sourdough and Yeast Fermentation 
The electrophoretic patterns characterize the composition of the albumin/globulin fractions 
before, during, and after sourdough and yeast fer entation (Figure 1). In general, sourdough 6, 7, 
and 8, with a final pH 3.5–3.7, showed a ore intensive hydrolysis, and β-amylases with a molecular 
size around 60 kDa ere degraded after sourdough fermentation, while they remained present after 
conventional flour and yeast fermentation (Figure 1A). After heat denaturation, yeast dough 2 and 5, 
extracted at a lower pH of 4.6, lead to precipitation of most β-amylases compared to yeast dough 1, 
3, and 4, with the higher pH of 5.5, 5.4, and 5.6. Dough 1, 3, and 4 showed the same gel band patterns 
as native flour. In sourdough 6, 7, and 8, increased protein products of low molecular weight around 
14 kDa were present (Figure 1B). Proteolysis in chemically acidified doughs and in sourdoughs has 
been attributed to gluten-associated aspartic proteases [28]; therefore, sourdough fermentation was 
also conducted in the presence of Pepstatin-A, an inhibitor of aspartic proteases, and in the presence 
of E64, an inhibitor of cysteine peptidases (Figure 2A). Proteolysis in sourdoughs was inhibited by 
Pepstatin-A but not by E-64, confirming the pH-dependent role of aspartic proteases on protein 
modifications (Figure 2A). 
 
Figure 1. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) under reducing 
condition of (A) the albumin/globulin extract of yeast-fermented doughs and sourdoughs, and (B) 
albumin/globulin extract of yeast-fermented doughs and sourdoughs after heat treatment. The pH 
value after fermentation is indicated below. Dough 1, yeast-fermented dough at 30 °C for 1 h; 2, yeast-
fermented dough at 30 °C for 17 h; 3, yeast-fermented dough at 4 °C for 17 h; 4, yeast-fermented dough 
with glutathione at 30 °C for 1 h; 5, yeast-fermented dough with glutathione at 30 °C for 17 h; 6, 
chemically acidified dough, pH 3.5, at 30 °C for 17 h; 7, wheat sourdough at 30 °C for 17 h; 8, 
chemically acidified dough, pH 3.5, with glutathione at 30 °C for 17 h; F, wheat flour. The -
amylase/trypsin inhibitor (ATI) proteins migrate in the range of molecular weight 12–15 kDa. 
. i
f (A) the albumin/globulin extract of yeast-fermente doughs and sourdoughs, and
(B) albumin/globulin extract of y ast-fermented dough an sourdoughs fter heat reatment.
The pH value after fermentation is indicated below. Dough 1, yeast-fermented d ug at 30 ◦C
fo 1 h; 2, yeast-fermented dough at 30 ◦C for 17 h; 3, yeast-fermented dough at 4 ◦C for 17 ;
4, yeast-ferment d dough with glutathione at 30 ◦C for 1 h; 5, yeast-fermented dough with glutathione
at 30 ◦C for 17 h; 6, chemically acidified dough, pH 3.5, at 30 ◦C f r 17 h; 7, wheat sourdough at
30 ◦C for 17 h; 8, chemically acidified dough, pH 3.5, with glutathione at 30 ◦C for 17 h; F, wheat flour.
The α-amylase/trypsin inhibitor (ATI) proteins migrate in the range of molecular weight 12–15 kDa.
Foods 2020, 9, 943 8 of 17Foods 2020, 9, x FOR PEER REVIEW 8 of 18 
 
 
Figure 2. Effect of protease inhibitors on the wheat sourdough albumin/globulin extract and 
fluorescence-labelled ATI tetramer. (A) SDS-PAGE of albumin/globulin extract. (a) control before 
fermentation, (b) rye starter-wheat sourdough, pH was 3.6 after 17 h fermentation, (c) rye starter-
wheat sourdough in the presence of 20 µM aspartic proteinase inhibitor Pepstatin-A, pH was 3.7 after 
17 h fermentation, (d) rye starter-wheat sourdough in the presence of 10 µM cysteine proteinase 
inhibitor E-64, pH was 3.6 after 17 h fermentation. The replicates were from two individual 
fermentation. (B) Size-exclusion chromatogram of fluorescein isothiocyanate (FITC)-labelled ATI 
tetramer after sourdough fermentation in the presence of protease inhibitors. The samples were 
treated the same as in (A). Fluorescent detector was set at excitation 488 nm and emission 530 nm. 
Elution volume of molecular marker bovine serum albumin (66 kDa) and lysozyme (14 kDa) was 
indicated in broken lines. 
3.2. Amylase Inhibitory Activity of Dough Albumin/Globulin Extracts 
β-Amylases were first precipitated before comparing the amylase inhibitory activity of 
albumin/globulin extracts of sourdough and yeast-fermented dough. The inhibitory activity of yeast-
fermented dough showed the same level as in the original flour, both against α-amylase from porcine 
pancreas (PPA) and Tenebrio molitor (TMA). However, the inhibitory activity of sourdough showed a 
significantly lower inhibitory activity than yeast-fermented dough and native flour in both the PPA 
and TMA assays (Figure 3). 
 
Figure 2. Effect of protease inhibitors on the wheat sourdough albumin/globulin extract and
fluorescence-labelled ATI tetramer. (A) SDS-PAGE of albumin/globulin extract. (a) control before
fermentation, (b) rye starter-wheat sourdough, pH was 3.6 after 17 h fermentation, (c) rye starter-wheat
sourdough in the presence of 20 µM aspartic proteinase inhibitor Pepstatin-A, pH was 3.7 after 17 h
fermentation, (d) rye starter-wheat sourdough in the presence of 10 µM cysteine proteinase inhibitor
E-64, pH was 3.6 after 17 h fermentation. The replicates were from two individual fermentation.
(B) Size-exclusion chromatogram of fluorescein isothiocyanate (FITC)-labelled ATI tetramer after
sourdough fermentation in the presence of protease inhibitors. The samples were treated the same
as in (A). Fluorescent detector was set at excitation 488 nm and emission 530 nm. Elution volume of
molecular marker bovine serum albumin (66 kDa) and lysozyme (14 kDa) was indicated in broken lines.
3.2. Amylase Inhibitory Activity of Dough Albumin/Globulin Extracts
β-Amylases were first precipitated before comparing the amylase inhibitory activity of
albumin/globulin extracts of sourdough and yeast-fermented dough. The inhibitory activity of
yeast-fermented dough showed the same level as in the original flour, both against α-amylase from
porcine pancreas (PPA) and Tenebrio molitor (TMA). However, the inhibitory activity of sourdough
showed a significantly lower inhibitory activity than yeast-fermented dough and native flour in both
the PPA and TMA assays (Figure 3).
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 Figure 3. Inhibitory activity of the albumin/globulin extract after heat treatment against α-amylase
from (A) yellow mealworm Tenebrio molitor, and (B) from porcine pancreas. D5, yeast-fermented dough;
D7, wheat sourdough. Each letter indicates groups with statistical difference (p < 0.05, a vs. b) using
triplicates and one-way analysis of variance (ANOVA) with Tukey’s honest significance test (HSD).
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3.3. Free Thiol Measurement of Dough Albumin/Globulin Extracts
The free thiol concentration of the dough albumin/globulin extracts correlated with dough pH
(Figure 4). Short-fermented yeast dough had the same level of free thiols as the original wheat flour.
With the lower pH in doughs 2 and 5, the free thiol groups slightly increased. Sourdough fermentation
systems 6, 7, and 8 produced the highest level of free thiols that were significantly higher than in
short-time yeast-fermented doughs. There was no significant difference between chemically acidified
dough and rye starter wheat sourdough.
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characterized by size exclusion chromatograph and tandem mass spectrometry (MS/MS). Heat 
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TMA (data not shown). In SDS-PAGE, non-covalently assembled ATI tetramers were de-assembled 
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peptides (Score 295, protein sequence coverage 33%), and Band 2 consisted of the ATI CM2 subunit 
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lyophilized ATI tetramer could be reconstituted in native form with molecular weight 60 kDa (Figure 
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Figure 4. Free thiol groups in the albumin/globulin extracts of doughs. The number indicates the dough
systems described in Figure 1. Dough 1, yeast-fermented dough at 30 ◦C for 1 h; 2, yeast-fermented
dough at 30 ◦C for 17 h; 3, yeast-fermented dough at 4 ◦C for 17 h; 4, yeast-fermented dough with
glutathione at 30 ◦C for 1 h; 5, yeast-fermented dough with glutathione at 30 ◦C for 17 h; 6, chemically
acidified dough, pH 3.5, at 30 ◦C for 17 h; 7, wheat sourdough at 30 ◦C for 17 h; 8, chemically
acidified dough, pH 3.5, with glutathione at 30 ◦C for 17 h; F, wheat flour. Bars that do not share a
common superscript differ significantly (p < 0.05, one-way ANOVA with Tukey’s honest significance
test (HSD) analysis).
3.4. Characterization and Identification of ATI
ATI were quantitatively extracted and tetramers of molecular weight around 60 kDa were
characterized by size exclusion chromatograph and tandem mass spectrometry (MS/MS). Heat treatment
denatured β-amylases, while inhibitory activity of ATI was retained both against PPA and TMA
(data not shown). In SDS-PAGE, non-covalently assembled ATI tetramers were de-assembled to
monomers by SDS-PAGE in reducing condition. In MS/MS analysis, Band 1 of the 60 kDa tetrameric
ATI-fraction consisted of the ATI CM3 subunit (UniProt P17314), with four unique peptides (Score 295,
protein sequence coverage 33%), and Band 2 consisted of the ATI CM2 subunit (UniPro P16851),
with one unique peptide (Score 115, protein sequence coverage 17%) (Supplementary Figure S1).
Size exclusion chromatography demonstrated that the purified and lyophilized ATI tetramer could be
reconstituted in native form with molecular weight 60 kDa (Figure 5).
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2% (m/v) dithiothreit l. (1) Molecular w ight standard, (2) Commercial Sigma ATI control, containing
mainly onomeric and dimeric ATI 0.19, 0.28, and 0.53 [14], and (3) ATI tetramer isolate. Size-exclusi n
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14 kDa (11.4 mL). As determined by mass spectrometry, Band 1 consists of the ATI tetramer CM3
subunit and Band 2 of the ATI tetramer CM2 subunit.
3.5. Behavior of ATI in Mini-Dough Systems
To determine the influence of yeast and sourdough fermentation on the changes of the ATI
in bread-making, tetrameric ATI were labelled with fluorescein isothiocyanate, and added to
sourdoughs or bread dough. Yeast bread was produced with a straight standard dough process
and type I sourdough bread was produced with two stages of fermentation. For yeast bread
fermentation, the fluorescence-labelled ATI was added directly at the beginning of the yeast fermentation.
For sourdough bread-making, fluorescence-labelled ATI was added at two stages respectively, the first
stage at the beginning of sourdough fermentation, and the second stage at the bread dough yeast
fermentation. Moreover, sourdoughs were fermented with a multi-strain sourdough obtained from
a bakery, or with defined and isogenic strains of F. sanfranciscensis that differ only with respect to
glutathione reductase activity. To confirm that the fermentation was performed by the same strain,
the melting temperature of amplicons from DNA isolated from sourdoughs was compared to the
melting temperature of amplicons from DNA from pure cultures. All melting curves consisted of a
single peak matching the peak obtained from the reference culture, confirming that the fermentation
microbiota were identical to the inoculum. In sourdoughs fermented with pure cultures, the bacterial
cell count reached 8.4–8.7 log CFU g−1, and the pH dropped to 4.0; in the multiple-strain sourdough,
the pH dropped to 3.6 and the cell count reached 9.6 log CFU g−1.
The fate of ATI was initially monitored by size-exclusion chromatography, to identify dissociation
of the tetramer to monomers, and proteolytic degradation. In yeast-fermented bread, fermentation
had no effect on the molecular size of ATI tetramers, and only heat treatment induced a shift in the size
distribution of ATI tetramers towards monomers (Figure 6A). In chemically acidified doughs acidified
to pH 5.0, the ATI tetramers added stayed intact throughout sourdough fermentation (Figure 6B).
When ATI was added to bread dough that also included chemically acidified dough incubated at
pH 5.0, the yeast fermentation and heat treatment affected the distribution of ATI tetramers only slightly
(Supplementary Figure S1B). In the wheat sourdoughs, fermentation drastically reduced ATI tetramers
(Figure 6C). For the ATI dosed to bread dough that included rye starter-wheat sourdough, 36% of
ATI tetramer was transformed to monomer during yeast fermentation, and heat treatment further
reduced ATI (Supplementary Figure S2C). Sourdough fermentation in the presence of Pepstatin-A and
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E-64 indicated that the conversion of tetrameric ATI to smaller subunits was dependent on aspartic
proteases (Figure 2B).
Table 1. The pH value and bacterial cell count after fermentation in the mini-dough system, and ATI
tetramer degradation throughout the bread-making process. The degradation of ATI tetramers was
expressed as the ratio of the peak height of the ATI tetramer divided by the peak height of the ATI
monomer in size-exclusion chromatograms.
Bread System pH CFU g−1 log10 A1 A2 A3 A4 B1 B2 B3
I Fructilactobacillussanfranciscensis 4.01 ± 0.05 8.37 ± 0.05 1 0.62 0.62 0.56 1 1 0.61
II Fructilactobacillussanfranciscensis ∆gshR 4.07 ± 0.04 8.71 ± 0.03 1 0.64 0.63 0.55 1 1 0.63
III Control, pH 5.0 - - 1 1 1 0.61 1 1 0.60
IV Control, pH 4.0 - - 1 0.26 0.38 0.42 1 0.63 0.61
V Wheat sourdough 3.69 ± 0.04 9.57 ± 0.19 1 0.25 0.27 0.36 1 0.64 0.57
Note: For ATI dosed at the sourdough stage, A1: after sourdough mixing (control), A2: after lactobacilli fermentation,
A3: after yeast fermentation, A4: after baking. For ATI dosed at the bread dough stage, B1: after bread dough
mixing, B2: after yeast fermentation, B3: after baking. CFU: colony-forming unit.
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Figure 6. Size-exclusion chromatogram of fluorescein-labelled ATI in bread-making.
Panel (A): Yeast-ferme ted bread, Panel (B): (III) chemically acidified dough at pH 5.0,
Panel (C): (V) Rye starter-wheat sourdough. Fluorescence-labelled ATI was added to bread dough
Panel (A) or to sourdough Panels (B,C). ATI was extracted after mixing of sourdough, after sourdough
fermentation, or after mixing of bread dough, after proofing, and after baking. FITC-labelled ATI
was separated by size exclusion chromatography coupled to a fluorescent detector set at excitation
488 n and emission 530 nm. Chromatograms were normalized to the highest peak intensity in each
chromatogram and were offset by 0.4 RFU. The elution volume of the molecular marker bovine serum
albumin (66 kDa) was 7.25 mL, of lysozyme (14 kDa) was 9.86 mL, and of glutathione (307 Da) was
17.35 mL. The Roman number and the sample letters are the same as those indicated in Table 1.
ATI disassembly was estimated by calculating the ratio of the ATI tetramers to ATI monomers in
size exclusion chromatograms (Table 1). When FITC-labelled ATI was added to chemically acidified
doughs, the disassembly was more extensive after incubation at pH 4.0 when compared to doughs
incubated at pH 5.0 (Table 1). In doughs acidified to pH 4.0 as well as in wheat sourdough fermented
with a multi-species culture, less than 30% of the ATI remained as tetramers. After mixing of the bread
dough, proofing, and baking, less than 50% of the ATI remained as tetramers (Table 1). The disassembly
of ATI tetramers was less extensive in sourdoughs fermented with pure strains of F. sanfranciscensis,
and, notably, the expression of glutathione reductase did not affect ATI degradation (Table 1). Addition
of FITC-labelled ATI to bread dough that also included chemically acidified dough (acidified to pH 4.0
or 5.0), or sourdoughs fermented with pure or mixed strains of lactobacilli resulted in a less extensive
degradation of the ATI tetramer, and approximately 60% of the ATI tetramers remained intact (Table 1).
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Disassembly of FITC-labelled ATI during proofing was observed only in bread dough prepared with
chemically acidified dough (pH 4.0), or with multi-species sourdough (Table 1).
3.6. Inflammatory Bioactivity of Protein Extracts from Sourdoughs
To determine whether modifications of the ATI during sourdough fermentation also result in an
altered biological activity, the release of three pro-inflammatory cytokines that are induced by the
TLR4-stimulating activity of ATI were measured in quantitative ATI extracts of doughs fermented with
F. sanfranciscensis and F. sanfranciscensis ∆gshR (Figure 7). Sourdoughs fermented with pure strains of
Ls. sakei or Lm. reuteri were additionally included as controls (Figure 7). The induction of MCP-1 by
standardized extracts from sourdoughs was significantly reduced if sourdoughs were fermented by
wild-type strains of F. sanfranciscensis, Ls. sakei, or Lm. reuteri. Fermentation with F. sanfranciscensis
∆gshR did not reduce MCP-1 induction relative to the unfermented wheat control. The induction of
TNF-α by extracts from sourdoughs was reduced in sourdoughs fermented by all strains, including
F. sanfranciscensis ∆gshR (Figure 7).
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Figure 7. ATI bioactivity of whole wheat fermented by four Lactobacillus strains ATI were extracted
from freeze-dried doughs, and extracts added to toll-like receptor 4 (TLR4) expressing THP-1 human
monocytic cells. The release of monocyte chemoattractant protein-1 (MCP-1) and tumour necrosis
factor alpha (TNF-α) into the culture medium was quantified by enzyme-linked immunosorbent assay
(ELISA). (* p < 0.05; ** p < 0.01; *** p < 0.001).
4. Discussion
We studied the fate of wheat amylase trypsin inhibitors (ATI), specifically the prominent
tetramer-forming ATI CM3 and CM2, throughout sourdough and yeast-fermented bread-making.
The family of ATI proteins has recently become the focus of great concern, since wheat ATI
have been identified as important pro-inflammatory proteins in wheat and related grains,
with far-reaching consequences for human health [13–18]. We quantified ATI activity, biochemically
characterized their disassembly/degradation, and measured their pro-inflammatory activity in
differently fermented dough extracts, to show that disulfide-bond reduction and a pH-dependent
proteolytic disassembly/degradation of ATI tetramers occurred with sourdough fermentation.
The SDS-PAGE protein patterns showed that disassembly/degradation of ATI on sourdoughs
was more extensive when compared with yeast-fermented dough. ATI are water-soluble proteins and
therefore, are classified as albumins. The degradation of albumins, including ATI, in sourdoughs has
not been investigated before, as most previous studies have focused on the changes of gluten proteins
during sourdough fermentation [27,28,37]. Some gluten-derived hydrolysis products appeared in
the albumin/globulin fraction, but the hydrolysis products with bands smaller than 28 kDa that we
focused on and that largely correspond to ATI were not recognized by polyclonal gliadin antibody
(data not shown).
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The decrease of amylase inhibitory activity further supported the modification of the tetrameric
ATI-complex by sourdough fermentation. The increase of free thiols in sourdough suggested that
reduction of disulfide bonds indeed occurred in sourdoughs. Reduction of disulfide bonds can decrease
the inhibitory activity of ATI due to conformational alterations and unfolding, especially at higher
temperature, but also due to the fact that reduction of disulfide bonds that opens up the compact
protein structure makes the ATI more susceptible for proteolytic degradation [13].
Sourdough fermentation with heterofermentative lactobacilli generates reducing conditions
through glutathione reductase activity of lactobacilli, which reduces oxidized glutathione (GSSH) to
glutathione (GSH) [31]. The GSH and GSSH together undergo sulfhydryl/disulfide bond interchanges
with other disulfide-containing proteins [38]. Glutathione reductase activity of F. sanfranciscensis reduced
the concentration of ovotransferrin, an egg white allergen, in sourdough [39]. However, the present
study provided no evidence that glutathione reductase contributes to the reduction of ATI tetramers.
A possible reason is the production of extracellular GSH from the lactobacilli, since content of
low-molecular weight thiols was unchanged after 5 h of fermentation, with a decrease only at the
beginning of the fermentation (3.5 h) [40]. When comparing yeast fermentation and sourdough
fermentation, there was no reduction of ATI in all yeast fermentation stages. It was shown before
that yeast fermentation increased yeast intracellular GSH [41], which after baking heat treatment,
was released. This may have affected the ATI, as a decrease in tetramers vs. monomers was observed
in all samples after heating. However, here, we could not determine the state of intra-chain disulfide
bonds of each ATI subunit by using size-exclusion chromatography.
The comparison of chemically acidified dough incubated at pH 4.0 or 5.0 with standard yeast
dough demonstrated that the pH was a crucial factor to reduce ATI integrity. In the chemically acidified
dough at pH 4.0, and in wheat sourdough (rye starter and single strains), monomer formation from ATI
tetramers was observed. This process was more intensive in the chemically acidified control at pH 4.0
and in rye starter-wheat sourdough, which rapidly acidified to pH 3.6, when compared to fermentations
with single strains of F. sanfranciscensis, which acidified to pH 4.0. In addition, sourdough fermentation
in the presence of the aspartic protease inhibitor Pepstatin-A indicated that the pH-dependent enzyme
activity of endogenous proteinases from the flour is instrumental [28]. Degradation of ATI CM proteins
from barley was also observed when incubated with purified aspartic proteinases from resting and
germinated barley seeds at pH 4.5 [42].
The role of sourdough fermentation in reduction and/or disassembly of bioactive ATI tetramers
was additionally by assessment of cytokines in the monocytic cell line THP-1. ATI-bioactivity
and their pro-inflammatory activity, which is finally responsible for adverse health effects [13–18],
were significantly reduced in sourdough extracts when compared to wheat flour, further suggesting a
significant inactivating effect of the sourdough fermentation on ATI bioactivity.
While the biochemical, analytical, and immunological experiments described in this study
consistently describe conversion of bioactive ATI tetramers during sourdough baking, the specific
contribution of this conversion to wheat tolerance in NCWS remains to be determined. First, the use of
sourdough in bread production is highly variable. The most extensive fermentation is achieved in type
I sourdough processes that use sourdough as the sole leavening agent, while many industrial processes
that employ sourdough in conjunction with baker’s yeast use only a small proportion of microbially
inactive sourdough [43]. Second, the conversion of ATI tetramer in sourdough bread-making is
only partial in this study and ATI monomers retain biological activity, albeit strongly reduced [14].
Third, while the use of sourdough to improve tolerance of wheat in NCWS has been suggested in
public and social media [44], it is poorly documented in the scientific literature. In a pilot study with IBS
patients [32], sourdough bread that contained less ATI as determined by SDS-PAGE was compared to
yeast-fermented bread in a clinical trial with IBS patients. Gastrointestinal symptoms after consumption
of control bread or sourdough bread were not significantly different. In a randomized, double-blind,
cross-over study, tolerance of pasta and bread fermented with lactobacilli and fungal proteases was
compared but only one questionnaire showed a lower score for IBS patients [45]. In both studies [32,45],
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effective degradation or reduction of ATI were poorly documented and the study subjects were
recruited from IBS patients. In IBS patients, effects of ATI degradation are confounded by reduced
levels of fermentable oligo-, di-, mono-saccharides, and polyols (FODMAPs) in sourdough bread.
FODMAPs contribute to adverse intestinal symptoms in a majority of IBS patients, and particularly,
the study of Laatikainen et al. [32] used bread where FODMAPs were strongly reduced in comparison to
the control. A small study with healthy volunteers documented that consumption of sourdough bread
improved satiety and reduced adverse gastrointestinal symptoms when compared to bread produced
with brewer’s yeast. Because sourdough bread also reduced breath hydrogen levels, reduced intestinal
fermentation of FODMAPs likely contributed to this effect [46]. Even a moderate reduction of ATI
in combination with reduced levels of FODMAPs and the potential reduction of other potentially
offending wheat proteins in sourdough bread may thus increase tolerance of wheat bread in some or in
many individuals with IBS or NCWS.
5. Conclusions
In conclusion, this work provided fundamental knowledge on the fate of pro-inflammatory wheat
ATI in different strategies of bread-making. ATI tetramers were disassembled/degraded and showed a
significantly lower pro-inflammatory bioactivity after sourdough fermentation. Sourdough was the
main leavening agent for bread production until the late 19th century. The introduction of baker’s yeast
in 1871 resulted in a gradual replacement of sourdough fermentation by a straight, short-term dough
processes. The use of sourdough in bread production has increased again in the past decade, owing to
the superior organoleptic properties of sourdough bread; this study, apart from prior studies related
to the degradation of FODMAPs during sourdough fermentation [47], suggested that the product
development strategy using sourdough fermentation may benefit the community by reducing the
severity of inflammatory non-celiac wheat sensitivity.
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